Stock listing

Dianthus Therapeutics, Inc.

Selected listing: A3ERZ4 · LS · EUR · DE

Dianthus Therapeutics, Inc. (Lang & Schwarz: A3ERZ4), Health Technology. Latest release Oct 1, 2026: Dianthus Therapeutics Announces Inducement Grants Under…

A3ERZ4:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3ERZ4
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Dianthus Therapeutics, Inc.

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

September 28, 2026

Dianthus Therapeutics to Participate in Three Investor Conferences During September

September 1, 2026

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results

August 4, 2026

Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

August 3, 2026

All Dianthus Therapeutics, Inc. news →

Research Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. company profile

View the public company page for Dianthus Therapeutics, Inc. on 6ix.

Dianthus Therapeutics, Inc. news

Read company news and market updates connected to Dianthus Therapeutics, Inc..

Dianthus Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Dianthus Therapeutics, Inc..